Dr. Jörg Taubel will be attending the ESC Congress 2024, held from 30th August to 2nd September in London and online. This event is the world’s leading gathering for cardiovascular professionals, bringing together experts to explore ground breaking research, innovative technologies, and collaborative efforts aimed at reducing the burden of cardiovascular disease.

The ESC Congress 2024 will feature a comprehensive programme, including sessions on the latest advancements in cardiovascular medicine, discussions on clinical practice guidelines, and presentations of cutting-edge research. Attendees will include cardiologists, researchers, healthcare professionals, and industry leaders dedicated to advancing cardiovascular health and improving patient outcomes.

To find out more, click here.

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more


AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event